Clinical Trials in Troyes, France
13 recruiting
Showing 1–17 of 17 trials
Recruiting
Not Applicable
Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context
ALK+ Non-Small-Cell Lung Carcinoma
Pfizer90 enrolled31 locationsNCT06487078
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1152 locationsNCT07064473
Recruiting
Not Applicable
Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis
Non-cystic Fibrosis Bronchiectasis
Physio-Assist622 enrolled57 locationsNCT06487273
Recruiting
Not Applicable
EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer
CancerGenetic Predisposition
Centre Georges Francois Leclerc613 enrolled6 locationsNCT04141462
Recruiting
Not Applicable
Same Day Ambulatory Appendectomy (SAMBA)
Appendicitis
Centre Hospitalier Universitaire de Nice1,400 enrolled33 locationsNCT05691348
Recruiting
Phase 3
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Polycythemia Vera
Italfarmaco220 enrolled90 locationsNCT06093672
Recruiting
UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
AstraZeneca300 enrolled52 locationsNCT06726720
Recruiting
Prospective Multicentre Mixed Methods Study to Explore Extubation Practices and Respiratory Outcomes in Extremely Preterm Neonates.
extubation failurePreterm neonateMechanical Ventilation+3 more
Centre Hospitalier Intercommunal Creteil100 enrolled31 locationsNCT06808997
Recruiting
Quality of Care in French HIV Infected Patients
HIV
DatAids30,000 enrolled39 locationsNCT02898987
Recruiting
DESTINY Breast Respond HER2-low Europe
Metastatic Breast CancerUnresectable Breast CancerHER2-low Expressing Breast Cancer
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1,155 enrolled211 locationsNCT05945732
Recruiting
Phase 2
Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary
Neuroendocrine Carcinoma
Centre Hospitalier Universitaire Dijon218 enrolled6 locationsNCT04325425
Recruiting
Not Applicable
Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.
Granulomatosis With Polyangitis
Hospices Civils de Lyon146 enrolled45 locationsNCT03290456
Recruiting
Not Applicable
HPV Self-sampling in the General Population
Cervical Cancer
International Agency for Research on Cancer6,000 enrolled2 locationsNCT06749847
Recruiting
Not Applicable
COsegregation of VARiants in Panel of Genes
Genetic PredispositionGene Mutation-Related Cancer
Institut Curie3,500 enrolled57 locationsNCT01689584
Recruiting
Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine
AML, Adult
French Innovative Leukemia Organisation230 enrolled42 locationsNCT06263387
Recruiting
Evaluation of Access to Screening for Post-partum Depression Via the Postnatal Interview Within 8 Weeks of Birth in Women Who Have Gave Birth at the Troyes Hospital ( DEPRESSIONPP )
Depression, Postpartum
Centre Hospitalier de Troyes400 enrolled1 locationNCT06469476
Recruiting
Not Applicable
Biological Dating of Cerebral Ischemia With GST-π/PRDX1 to Detect Patients With Stroke of Unknown Onset Within the Therapeutic Window of Thrombolysis
Stroke, Acute
Central Hospital, Nancy, France930 enrolled5 locationsNCT03364296